Marie Blonski

2.7k total citations
51 papers, 927 citations indexed

About

Marie Blonski is a scholar working on Genetics, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marie Blonski has authored 51 papers receiving a total of 927 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Genetics, 23 papers in Radiology, Nuclear Medicine and Imaging and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marie Blonski's work include Glioma Diagnosis and Treatment (39 papers), Radiomics and Machine Learning in Medical Imaging (22 papers) and Brain Metastases and Treatment (15 papers). Marie Blonski is often cited by papers focused on Glioma Diagnosis and Treatment (39 papers), Radiomics and Machine Learning in Medical Imaging (22 papers) and Brain Metastases and Treatment (15 papers). Marie Blonski collaborates with scholars based in France, United States and Italy. Marie Blonski's co-authors include Luc Taillandier, Hugues Duffau, Antoine Verger, Luc Bauchet, Fabien Rech, Guillaume Gauchotte, Amélie Darlix, Marie‐Hélène Baron, Johan Pallud and Patrick Beauchesne and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Neurosurgery.

In The Last Decade

Marie Blonski

47 papers receiving 920 citations

Peers

Countries citing papers authored by Marie Blonski

Since Specialization

Citations

This map shows the geographic impact of Marie Blonski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie Blonski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie Blonski more than expected).

Fields of papers citing papers by Marie Blonski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marie Blonski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie Blonski. The network helps show where Marie Blonski may publish in the future.

Co-authorship network of co-authors of Marie Blonski

This figure shows the co-authorship network connecting the top 25 collaborators of Marie Blonski. A scholar is included among the top collaborators of Marie Blonski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marie Blonski. Marie Blonski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	[177Lu]Lu-DOTATATE for refractory meningiomas: factors associated with the therapeutic response and initial tumor dosimetric data 2025 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Timothée Zaragori, N Garabédian, Marie Blonski, (unknown), Luc Taillandier, Laëtitia Imbert, Antoine Verger	0
2	PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): methodological application in [18F]-FDOPA PET imaging 2025 ·EJNMMI Research ·(unknown), (unknown), (unknown), Luc Taillandier, Marie Blonski, Laëtitia Imbert, Timothée Zaragori, Antoine Verger	0
3	The role of [18 F]FDOPA PET as an adjunct to conventional MRI in the diagnosis of aggressive glial lesions 2024 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Celso Pouget, Fabien Rech, Luc Taillandier, Marie Blonski, (unknown), Laëtitia Imbert, Timothée Zaragori, Antoine Verger	5
4	Health-related quality of life in 62 patients with diffuse low-grade glioma during a non-therapeutic and progression-free phase: a cross-sectional study 2024 ·Journal of Neuro-Oncology ·(unknown), Marie Blonski, (unknown), Fabien Rech, Luc Taillandier	1
5	Amino-acid PET as a prognostic tool after post Stupp protocol temozolomide therapy in high-grade glioma patients 2024 ·Journal of Neuro-Oncology ·(unknown), (unknown), Jason R. Becker, (unknown), Véronique Roch, (unknown), (unknown), Marie Blonski, Luc Taillandier, Timothée Zaragori, Antoine Verger	2
6	Added value of [18F]FDOPA PET to the management of high-grade glioma patients after their initial treatment: a prospective multicentre study 2023 ·European Journal of Nuclear Medicine and Molecular Imaging ·Jacques Darcourt, David Chardin, Véronique Bourg, Jocelyn Gal, Renaud Schiappa, Marie Blonski, (unknown), (unknown), Lydiane Mondot, Florence Le Jeune, Laurent Collombier, Aurélie Kas, Luc Taillandier, Antoine Verger	4
7	Radiological evolution of progestogen‐induced meningioma: A monocentric retrospective study 2023 ·Fundamental and Clinical Pharmacology ·(unknown), Romain Gillet, Marie Blonski, Fabien Rech, (unknown), Pierre Gillet, Luc Taillandier, Nadine Petitpain	2
8	Semi-automated segmentation methods of SSTR PET for dosimetry prediction in refractory meningioma patients treated by SSTR-targeted peptide receptor radionuclide therapy 2023 ·European Radiology ·(unknown), Timothée Zaragori, (unknown), (unknown), (unknown), Luc Taillandier, Marie Blonski, Véronique Roch, Pierre‐Yves Marie, Gilles Karcher, Laëtitia Imbert, Antoine Verger	6
9	Initial PCV Chemotherapy Followed by Radiotherapy Is Associated With a Prolonged Response But Late Neurotoxicity in 20 Diffuse Low-Grade Glioma Patients 2022 ·Frontiers in Oncology ·Marie Blonski, (unknown), (unknown), Celso Pouget, (unknown), (unknown), (unknown), (unknown), (unknown), Guillaume Gauchotte, Marie‐Hélène Baron, Fabien Rech, (unknown), (unknown), Antoine Verger, Guillaume Vogin, René Anxionnat, Jean-Marie Moureaux, Luc Taillandier	12
10	¹⁸F-FDOPA PET for the Noninvasive Prediction of Glioma Molecular Parameters: A Radiomics Study 2021 ·Journal of Nuclear Medicine ·Timothée Zaragori, Julien Oster, Véronique Roch, Gabriela Hossu, Mohammad B. Chawki, (unknown), Celso Pouget, Guillaume Gauchotte, Fabien Rech, Marie Blonski, Luc Taillandier, Laëtitia Imbert, Antoine Verger	39
11	Use of static and dynamic [18F]-F-DOPA PET parameters for detecting patients with glioma recurrence or progression 2020 ·EJNMMI Research ·Timothée Zaragori, (unknown), Pierre‐Yves Marie, Véronique Roch, (unknown), Guillaume Gauchotte, Fabien Rech, Marie Blonski, Zohra Lamiral, Luc Taillandier, Laëtitia Imbert, Antoine Verger	36
12	Integration of dynamic parameters in the analysis of 18F-FDopa PET imaging improves the prediction of molecular features of gliomas 2019 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Timothée Zaragori, Pierre‐Yves Marie, Véronique Roch, Guillaume Gauchotte, Fabien Rech, Marie Blonski, Zohra Lamiral, Luc Taillandier, Laëtitia Imbert, Antoine Verger	36
13	Long-term survival in patients with recurrent glioblastoma treated with bevacizumab: a multicentric retrospective study 2019 ·Journal of Neuro-Oncology ·(unknown), Nelly Étienne-Selloum, (unknown), Marie Blonski, Luc Taillandier, Véronique Lorgis, G. Noël, Guido Ahle, Alberto Durán-Peña, Mathieu Boone, Bruno Chauffert	9
14	A Probabilistic Atlas of Diffuse WHO Grade II Glioma Locations in the Brain 2016 ·PLoS ONE ·Sarah Parisot, Amélie Darlix, Cédric Baumann, Sonia Zouaoui, Yordanka Yordanova, Marie Blonski, Valérie Rigau, (unknown), Luc Taillandier, Luc Bauchet, Hugues Duffau, Nikos Paragios	43
15	CellSearch® technology applied to the detection and quantification of tumor cells in CSF of patients with lung cancer leptomeningeal metastasis 2015 ·Lung Cancer ·(unknown), Xianglei Wu, Émilie Le Rhun, Marie Blonski, (unknown), Luc Taillandier, Manoel de Carvalho, G Fauré	41
16	Imaging growth and isocitrate dehydrogenase 1 mutation are independent predictors for diffuse low-grade gliomas 2014 ·Neuro-Oncology ·Catherine Gozé, Marie Blonski, G. Maistre, Luc Bauchet, Edouard Dezamis, Philippe Page, Pascale Varlet, L. Capelle, Bertrand Devaux, Luc Taillandier, (unknown), (unknown)	39
17	Significant heterogeneity in the geographical distribution of diffuse grade II/III gliomas in France 2014 ·Journal of Neuro-Oncology ·Amélie Darlix, Sonia Zouaoui, Jean‐Marc Virion, Valérie Rigau, Hélène Mathieu‐Daudé, Marie Blonski, Germán Reyes-Botero, Faïza Bessaoud, Brigitte Trétarre, Fabienne Bauchet, Laurent Capelle, Michel Fabbro, Christine Kerr, Dominique Figarella‐Branger, Hugues Duffau, Luc Taillandier, Luc Bauchet	6
18	Velocity of tumor spontaneous expansion predicts long-term outcomes for diffuse low-grade gliomas 2013 ·Neuro-Oncology ·Johan Pallud, Marie Blonski, Emmanuel Mandonnet, Étienne Audureau, Denys Fontaine, Nader Sanai, Luc Bauchet, P Peruzzi, Marc Frénay, Philippe Colin, Rémy Guillevin, V. Bernier, Marie‐Hélène Baron, Jacques Guyotat, Hugues Duffau, Luc Taillandier, Laurent Capelle	110
19	Upfront Bevacizumab and Temozolomide or Fotemustine before Radiotherapy for Patients with Glioblastoma and Severe Neurological Impairment at Diagnosis 2012 ·Case Reports in Oncology ·(unknown), (unknown), Mathieu Boone, Marie Blonski, Alexandre Coutté, Amélie Darlix, Patrick Beauchesne, (unknown), Véronique Lorgis, Luc Taillandier, Bruno Chauffert	7
20	Combination of neoadjuvant chemotherapy followed by surgical resection as a new strategy for WHO grade II gliomas: a study of cognitive status and quality of life 2011 ·Journal of Neuro-Oncology ·Marie Blonski, Luc Taillandier, Guillaume Herbet, Igor Lima Maldonado, Patrick Beauchesne, Michel Fabbro, Chantal Campello, Catherine Gozé, Valérie Rigau, Sylvie Moritz‐Gasser, Christine Kerr, Roberta Rudà, Riccardo Soffietti, Luc Bauchet, Hugues Duffau	63

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact